Tranexamic Acid is an antifibrinolytic medication that prevents the breakdown of blood clots, assisting in the management of hemorrhage.
Tranexamic acid belongs to the antifibrinolytic class of medicines. It works by helping the body form stable blood clots when bleeding occurs. This ingredient is found in products such as Cyklokapron, which is available in Hong Kong under both brand and generic names.
In Hong Kong, the most common product containing tranexamic acid is Cyklokapron. It is supplied as tablets, oral solution, and injectable forms, allowing doctors to choose the route that best matches a patient’s needs. The tablet strength is usually 500 mg, while the injectable solution is commonly 100 mg/mL. Both brand-name and generic versions are listed on the Pharmacy and Poisons Board’s approved drug register.
Tranexamic acid is used for a range of bleeding-related situations, including:
These uses are supported by the Hong Kong Department of Health’s clinical guidelines, which classify tranexamic acid as an approved treatment for the above indications.
The drug blocks the breakdown of fibrin, a protein that forms the mesh-like structure of a blood clot. By slowing fibrinolysis, the clot remains intact longer, which helps stop bleeding. The effect usually begins soon after the medication is taken, making it useful for both acute bleeding episodes and planned surgical settings.
These reactions are generally mild and go away without medical intervention.
If any of these signs appear, seek immediate medical help.
Tranexamic acid may interact with:
Patients should check the full interaction list on the specific product’s information sheet.
Store Cyklokapron at room temperature, away from direct sunlight and moisture. The tablet and oral solution are intended for short-term use, typically covering the period around surgery or a bleeding episode. Always follow the instructions printed on the product label, as different formulations may have unique handling requirements. For precise dosing, administration steps, and any special precautions, refer to the individual medication’s patient leaflet.
Antifibrinolytic: A type of drug that slows the breakdown of blood clots. Fibrin: The protein strands that form the basic structure of a clot. Clotting disorder: A condition where the blood does not clot normally, leading to excessive bleeding or, conversely, a tendency to form clots.
This article offers general educational information about tranexamic acid as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing tranexamic acid may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.